122 related articles for article (PubMed ID: 17118848)
1. Correlation of COX-2 and K-ras expression to clinical outcome in gastric cancer.
Li M; Liu W; Zhu YF; Chen YL; Zhang BZ; Wang R
Acta Oncol; 2006; 45(8):1115-9. PubMed ID: 17118848
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
Mrena J; Wiksten JP; Thiel A; Kokkola A; Pohjola L; Lundin J; Nordling S; Ristimäki A; Haglund C
Clin Cancer Res; 2005 Oct; 11(20):7362-8. PubMed ID: 16243808
[TBL] [Abstract][Full Text] [Related]
3. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between cyclooxygenase- 2 expression and angiogenesis in patients with gastric cancer].
Sun WH; Sun YL; Fang RN; Ou XL; Xue QP; Shao Y; Xu HC; Cheng YL
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jul; 8(4):343-7. PubMed ID: 16167259
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
7. Concomitant overexpression of cyclooxygenase-2 in HER-2-positive on Smad4-reduced human gastric carcinomas is associated with a poor patient outcome.
Okano H; Shinohara H; Miyamoto A; Takaori K; Tanigawa N
Clin Cancer Res; 2004 Oct; 10(20):6938-45. PubMed ID: 15501972
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 is an independent prognostic factor in gastric carcinoma patients receiving adjuvant chemotherapy and is not associated with EBV infection.
Park ES; Do IG; Park CK; Kang WK; Noh JH; Sohn TS; Kim S; Kim MJ; Kim KM
Clin Cancer Res; 2009 Jan; 15(1):291-8. PubMed ID: 19118057
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression and its association with angiogenesis, Helicobacter pylori, and clinicopathologic characteristics of gastric carcinoma.
Yamac D; Ayyildiz T; Coşkun U; Akyürek N; Dursun A; Seckin S; Koybasioglu F
Pathol Res Pract; 2008; 204(8):527-36. PubMed ID: 18462890
[TBL] [Abstract][Full Text] [Related]
12. Expression of 15-PGDH is downregulated by COX-2 in gastric cancer.
Liu Z; Wang X; Lu Y; Han S; Zhang F; Zhai H; Lei T; Liang J; Wang J; Wu K; Fan D
Carcinogenesis; 2008 Jun; 29(6):1219-27. PubMed ID: 18174234
[TBL] [Abstract][Full Text] [Related]
13. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
14. [Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof].
Zhang FH; Zhou YN; Li GZ; Li Q; Lu B; Zhang ZY; Wu ZQ; Fan P; Hao TJ
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(46):3279-82. PubMed ID: 19159555
[TBL] [Abstract][Full Text] [Related]
15. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
16. Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer.
Dai N; Bao Q; Lu A; Li J
Oncology; 2007; 72(1-2):89-96. PubMed ID: 18004082
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues.
Choi MG; Sohn TS; Park SB; Paik YH; Noh JH; Kim KM; Park CK; Kim S
Eur Surg Res; 2009; 42(4):223-9. PubMed ID: 19279387
[TBL] [Abstract][Full Text] [Related]
18. Clinical implication of CXCL12 expression in gastric cancer.
Ishigami S; Natsugoe S; Okumura H; Matsumoto M; Nakajo A; Uenosono Y; Arigami T; Uchikado Y; Setoyama T; Arima H; Hokita S; Aikou T
Ann Surg Oncol; 2007 Nov; 14(11):3154-8. PubMed ID: 17653799
[TBL] [Abstract][Full Text] [Related]
19. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
[TBL] [Abstract][Full Text] [Related]
20. Expression of COX-2, survivin in regional lymph node metastases of gastric carcinoma and the correlation with prognosis.
Li Y; Tan BB; Fan LQ; Zhao Q; Liu Y; Wang D
Hepatogastroenterology; 2010; 57(104):1435-41. PubMed ID: 21443099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
